‘Butter and Eggs Money" and a Gubernatorial Veto
By Dr. Matthew Watson
Scheper-Hughes, professor of medical anthropology at UC Berkeley and
director of Organs
Watch, is one of the opponents of the legislation that would have
permitted women to sell their eggs for research. Today she filed the
following comment on the “troubling mindset” item on the
California Stem Cell Report.
“Jerry Brown's
veto of AB926
which would allow young women to be paid for multiple egg extractions
for scientific research is one for the gals. In western Ireland
women secreted away their 'butter
and eggs'
money in anticipation of hard times. In my day every smart girl had
her 'mad money' to escape a bad situation. Secret cash for young
women is a great idea, but not when it turns on multiple cycles of
pumping powerful hormones associated (in other contexts) with ovarian
cancer into young women's bodies to produce 30 or 60 eggs a month.
That's not promoting gender equity no matter what some of our best
Democratic women leaders have to say. Selling sperm and selling eggs
are a totally different matter. One is pleasurable and safe,
the other is a complicated and invasive procedure. We need good
science and good research and freedom of choice and action. We
also need protection from false advertising. There are no
evidence based, long term studies of the effects of these hormone
injections on women ten or twenty years after the fact. Let's fund
those needed longitudinal and cohort studies and hope for the best.
In the meantime, women had best stick to 'butter and eggs' money. It
doesn't pay a lot, but it's less painful and a heck of a lot safer.”
Source:
Stem Cell Therapy
Comments Off on ‘Butter and Eggs Money" and a Gubernatorial Veto |
August 18th, 2013
Bonilla: Veto of Pay-for-Eggs Bill Shows Troubling Mindset
By Dr. Matthew Watson
assailed Democratic Gov. Jerry Brown's “mindset” as “particularly
troubling” in his veto of legislation that would have allowed women
to sell their eggs for scientific research.
Susan Bonilla, D-Concord, in response to Brown's action on her
fertility-industry sponsored bill, AB926, which would have removed a
ban on compensation for women who provide eggs for research.
 |
| Susan Bonilla Photo from California Legislature |
“Not everything in life is for sale
nor should it be.”
Weekly, quoted Bonilla as saying,
“It (the governor's veto) shows a
glaring inconsistency...The veto statement was very overreaching in
the fact that it was making very broad statements about what women
should be able to do, and while it's not legislation it certainly
goes to a mindset that the governor has that I find particularly
troubling.”
“Market-driven compensation of donors
by donor agencies and prospective parents continues unchecked.”
said the governor's veto “is a regressive action that denies
thousands of women the prospect of medical fertility breakthroughs.”
She said,
“Many women...will be denied hope and
the possibility of giving birth to a child because research on their
behalf has been halted in California.”
in egg-related research, such as that involving stem cells, should
be compensated, just as men are for their sperm. Women who provide
eggs for fertility purposes can be legally compensated up to any
amount. The current market runs about $10,000 or so per egg cycle but can be much
higher.
affected a ban on compensation involving research funded by the $3
billion California stem cell agency. It would have taken a 70 percent
vote of each house to alter that restriction, compared to a simple
majority for Bonilla's bill. The super, super-majority requirement
was written into state law by Proposition 71, the measure that
created the stem cell agency.
would attempt to override the governor's veto, which would require a
2/3 vote of each house.
Center for Genetics and Society in Berkeley, called the veto a
“welcome development.”
director of the center, said,
“It would be unconscionable to
expand the commercial market in women’s eggs without obtaining
significantly more information about the risks of retrieving them.”
on the veto of the bill: Los Angeles Times, Sacramento Bee, an
additional story from late yesterday on Capitol Weekly, TheAssociated Press and National Review.
Source:Stem Cell Therapy
Comments Off on Bonilla: Veto of Pay-for-Eggs Bill Shows Troubling Mindset |
August 18th, 2013
California Gov. Jerry Brown Vetoes Pay-for-Eggs Legislation
By Dr. Matthew Watson
vetoed a fertility industry-backed measure that would have permitted
women to sell their eggs for the purposes of scientific research.
“Not everything in life is for sale
nor should it be.”
compensation of women who provide their eggs for scientific purposes.
The measure would not have changed existing law that allows women to
be paid for their eggs for IVF purposes with fees that range up to
$50,000. The bill also would not have affected the ban on compensation for
eggs for research that is financed by the $3 billion California stem
cell agency.
Assemblywoman Susan Bonilla, D-Concord, was sponsored by the American
Society for Reproductive Medicine and easily swept through the Democratic-dominated legislature. Bonilla said the measure would have placed women on an
equal footing with men, who are paid for their sperm contributions
for research. She also said that it would help to encourage more
research into fertility issues.
complained that not enough women are willing to donate eggs without
compensation, but stem cell researchers were not publicly involved in
supporting the bill.
confidently predicted that Brown, a Democrat like Bonilla, would sign the bill. The governor's
action could be overridden by a 2/3 vote of each house of the
Legislature. It is not clear whether Bonilla will make such an
attempt.
message:
"Not everything in life is for sale
nor should it be."This bill would legalize the payment of
money in exchange for a woman submitting to invasive procedures to
stimulate, extract and harvest her eggs for scientific research."The questions raised here are not
simple; they touch matters that are both personal and philosophical.
"In medical procedures of this kind,
genuinely informed consent is difficult because the long-term risks
are not adequately known. Putting thousands of dollars on the table
only compounds the problem."Six years ago the Legislature, by
near unanimity, enacted the prohibition that this bill now seeks to
reverse. After careful review of the materials which both supporters
and opponents submitted, I do not find sufficient reason to change
course.
"I am returning this bill without my
signature."
Source:Stem Cell Therapy
Comments Off on California Gov. Jerry Brown Vetoes Pay-for-Eggs Legislation |
August 18th, 2013
Duane Roth: Ecumenical Innovator for San Diego and Biotech
By Dr. Matthew Watson
a sterling look at the contributions that Duane Roth, co-vice
chairman of the California stem cell agency, made before his untimely
death as the result of a bicycle accident.
a host of comments concerning Roth's involvement in the San Diego
community, ranging from biotech to action sports companies. The
headline on the piece read, “The Connector Who Wired up a Regional
Innovation Economy.”
63, Roth was CEO of Connect, a nonprofit organization that supported
technology and innovation and one that he was credited with reviving.
Bigelow also wrote,
“Once California voters approved a
2004 ballot proposition that authorized the issuance of $3 billion in
grants for stem cell R&D, (Mary) Walshok (associate vice
chancellor for public programs at UC San Diego) said Roth also played
a key role in bringing together UCSD, Scripps, Salk, and
Sanford-Burnham to create the Sanford Consortium for Regenerative
Medicine. In fact, Walshok doubts whether anyone but Duane Roth could
have brought the four major research centers together.”
services Friday attended by about 1,000 persons was Bill Walton, the
former UCLA and NBA great, who grew up in San Diego.
“Walton, the NBA Hall of Famer who
has led San Diego Sports Innovators as a division of Connect since
2010, said Roth became a business mentor to him. In his comments
Friday afternoon, Walton said Roth inspired him to be a better
person, and he counted Roth among the people who had the biggest
influence on his life—a list that included his own father, UCLA
coach John Wooden, sportscaster Chick Hearn, author David Halberstam,
and Jerry Garcia of the Grateful Dead.”
and pragmatic advocate for innovation who could work with persons who
did not always agree with him on all issues. He was a conservative
and active Republican, but his co-vice chair at at the stem cell
agency, Art Torres, former chairman of the state Democratic Party, on
more than one occasion has lauded Roth's ability to work together.
Friday by Don Rosenberg, an executive vice president and general
counsel at Qualcomm.
“'Duane and I were as different as
two people can be,' Rosenberg said during his eulogy at the Church of
the Immaculata. 'Duane was born in Iowa, baptized in the Mennonite
church, a Republican. And me, raised in Brooklyn, Jewish, a Democrat.
We quickly learned we had more in common. We were kindred spirits. We
liked the same things: Bikes, biking, cars, and people.'”
Source:Stem Cell Therapy
Comments Off on Duane Roth: Ecumenical Innovator for San Diego and Biotech |
August 18th, 2013
A $6 Billion Question: Progress of the California Stem Cell Agency
By Dr. Matthew Watson
Internet and throughout the world.
rare headline that sounds a harshly different note:
one form or another, a request/question posed last month by an
anonymous reader of the California Stem Cell Report. The comment came
on an item about the California stem cell agency's $70 million plan
to establish a network of “Alpha” stem cell clinics in
California.
“It would be nice to have an overall
update on how much as been spent on California's stem cell research
project and what progress has been made.”
agency has given away $1.8 billion. The agency says it has made
tremendous progress and expects to make even more with the about $600
million it has left. The prestigious Institute of Medicine has said the
agency has “achieved many notable results.”
evaluation has been made of the details of the agency's scientific
contributions, specific grant awards or its impact on the field of
regenerative medicine. No one has attempted to genuinely assess
whether the work of the agency is or will be worth the roughly $6
billion(including interest) that California taxpayers will have paid
for the agency's ambitious efforts.
towards what?” Is the progress to be measured against the promises
of the 2004 ballot campaign that resulted in creation of the stem
cell agency or more modest goals that eschew the hype of the
campaign?
created a sort of contract with voters. They were led to
believe nine years ago that the cures for diseases that the campaign said afflict nearly
one-half of all California families were, in fact, right around the corner. Few,
if any California stem cell researchers were publicly warning that a
hard and long, long slog remained before therapies reached patients.
British newspapers, The Guardian and Observer, shed some light on the
early, rosy promises of stem cell science compared to the world as it exists
today.
“(B)iomedical engineer Professor
Michael Sefton declared that within 10 years, scientists would have
grown an entire heart, fit for transplant. 'We're shooting big,' he
said. 'Our vision is that we'll be able to pop out a damaged heart
and replace it as easily as you would replace a carburetor in a car.'“Fifteen years on, however, we've had
some liver cells, eye cells, even a lab-grown
burger, but no whole human organs. We could be forgiven for
asking: where's our heart? It does seem strange that a field stoking
so much excitement could be so far off the mark. Speaking last week
about the vision that he and his colleagues outlined in 1998, Sefton
said they had been 'hopelessly naïve.' As time plodded on and an
understanding of the biological complexity increased, the task seemed
bigger and bigger. Even now, a cacophony of headlines later, we are
not much further ahead.
“Chris Mason is a professor of
regenerative medicine at University College London and believes that
concentrating on organ regeneration is missing a trick. 'These organs
are immensely complex,' he said. 'They've got nerves, blood vessels,
in the case of the liver, a bile system – there are huge degrees of
complexity. These things take a long time to grow in humans, let
alone in the lab without all the natural cues that occur in the
growing embryo.'"
said,
“There's a tension in medical
research between the glory of the big discovery and the
assiduous commitment to real application. 'We're hoping the scope and
possibilities of this project will catch the public's imagination,'
Sefton concluded in 1998. It did, but perhaps the public's
imagination isn't always what science should be vying for.”
stem cell agency has made a significant contribution to stem cell
science, although the size of that contribution – beyond dollars –
remains to be measured. For now, the key for the agency and the
public is to focus on activities that will generate the greatest value over the
next few years and advance the science that has already been financed
by the agency.
report said,
“The challenge of moving its research
programs closer to the clinic and California’s large biotechnology
sector is certainly on CIRM’s agenda, but substantial achievements
in this arena remain to be made.”
http://feedproxy.google.com/~r/blogspot/uqpFc/~3/O78NzUdZE88/a-6-billion-question-progress-of.html
Stem Cell Therapy
Comments Off on A $6 Billion Question: Progress of the California Stem Cell Agency |
August 18th, 2013
Stem Cell Agency’s Duane Roth Eulogized at Memorial Services
By Dr. Matthew Watson
services last week for Duane Roth, co-vice chairman of the California
stem cell agency, who died at the age of 63 following a bicycle
accident.
“A Who’s
Who of San Diego’s technology, business and civic community
gathered Friday to bid farewell to Duane Roth.
The biotech entrepreneur, community leader and director of Connect
died last weekend of injuries sustained in a cycling accident.
“Among
attendees were Gayle and former Gov. Pete
Wilson, who had just celebrated his upcoming 80th birthday
with former colleagues and friends in Sacramento, county
Supervisor Ron Roberts, former
Assemblyman Nathan Fletcher, Chamber
head Jerry Sanders, Preuss School
benefactors Peggy and Peter
Preuss, SDG&E CEO Jessie Knight,
and many biotech and high-tech leaders. These included Irwin
Jacobs, Ted Waitt and Denny
Sanford.”
Source:Stem Cell Therapy
Comments Off on Stem Cell Agency’s Duane Roth Eulogized at Memorial Services |
August 18th, 2013
‘Paradigm Shift’ — Researchers as Patient Advocates?
By Dr. Matthew Watson
scientist to break into “print” in that bastion of American
capitalism, Forbes magazine. Much less one from that perceived
antithesis of free enterprise, Reed College.
Davis has done just that.
Friday in the wake of the announcement Knoepfler will be honored with
a “national advocacy” award by the Genetics Policy Institute.
 |
| Paul Knoepfler -- Advocate for a "new ethos" UC Davis photo |
English literature from Reed in 1989, is being recognized for his
activities as a stem cell blogger since 2009.
an email,
“With many stumbles, face plants,
land mines, and even a few threats of litigation and career
retaliation along the way for the last three and half a years, I
turned my crazy idea into a reality.”
“But it was only possible,
(Knoepfler) added, with guidance from many patient advocates and
bloggers in other fields who generously helped him learn the ropes of
blogging.
“'I see this award as a validation of
the notion that advocacy by scientists has become a valued part of
the stem cell field,' he said.
“'My hope is to catalyze a continuing
paradigm shift whereby stem cell scientists and biomedical scientists
more generally have a new ethos that not just accepts, but also
deeply values advocacy.'”
Source:Stem Cell Therapy
Comments Off on ‘Paradigm Shift’ — Researchers as Patient Advocates? |
August 18th, 2013
Stem Cell Therapy Treatment for Peripheral Nerve Injury by Dr Alok Sharma, Mumbai, India. – Video
By JoanneRUSSELL25
Stem Cell Therapy Treatment for Peripheral Nerve Injury by Dr Alok Sharma, Mumbai, India.
Improvement seen in just 5 day after Stem Cell Therapy Treatment for Peripheral Nerve Injury by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. Dee...
By: Neurogen Brain and Spine Institute
See the original post:
Stem Cell Therapy Treatment for Peripheral Nerve Injury by Dr Alok Sharma, Mumbai, India. - Video
Uncategorized
Comments Off on Stem Cell Therapy Treatment for Peripheral Nerve Injury by Dr Alok Sharma, Mumbai, India. – Video |
August 17th, 2013
Vet-Stem, Inc. Founder and CEO, Robert Harman, DVM, Invited to Speak at the Adult Stem Cell Therapy and Regenerative …
By daniellenierenberg
Poway, California (PRWEB) August 15, 2013
Robert J. Harman, DVM, Chief Executive Officer of Vet-Stem, Inc., a leading Regenerative Veterinary MedicineTM company located in San Diego, California, has been invited back to speak at the Adult Stem Cell Therapy and Regenerative Medicine Conference in Cleveland, Ohio August 19-21, 2013. The conference is presented by The National Center for the Regenerative Medicine (NCRM), Case Western Reserve University (CWRU), Cleveland Clinic (CC), and University Hospitals Case Medical Center (UHCMC) to bring together a global perspective on regenerative medicine and adult stem cell therapy.
Dr. Harman is scheduled as the first speaker of Session II titled Disease Models for Adult Stem Cell Therapy, and his presentation is One Medicine Natural Veterinary Disease Models.
He stands alone in his expertise in the field of Regenerative Veterinary Medicine among the 273 attendees from 100 institutions in 17 countries that make up the conference. Dr. Harman draws his knowledge from more than 10,000 horse, dog and cat patients treated over the last 10 years in both the U.S. and Canada using proprietary Vet-Stem technology.
Dr. Harman is sharing the podium with Case Western Reserve Universitys own Dr. Arnold Caplan, and revolutionary regenerative medicine companies such as BioTime, Terumo BCT, STROMALab, and Pfizer. Dr. Caplan, a technology pioneer in cell-based therapies in Regenerative Medicine, is a scientific advisor to Vet-Stem, Inc.
About Vet-Stem, Inc.
Vet-Stem, Inc. was formed in 2002 to bring regenerative medicine to the veterinary profession. The privately held company is working to develop therapies in veterinary medicine that apply regenerative technologies while utilizing the natural healing properties inherent in all animals. As the first company in the United States to provide an adipose-derived stem cell service to veterinarians for their patients, Vet-Stem, Inc. pioneered the use of regenerative stem cells in veterinary medicine. The company holds exclusive licenses to over 50 patents including world-wide veterinary rights for use of adipose derived stem cells. In the last decade over 10,000 animals have been treated using Vet-Stem, Inc.s services, and Vet-Stem is actively investigating stem cell therapy for immune-mediated and inflammatory disease, as well as organ disease and failure. For more on Vet-Stem, Inc. and Veterinary Regenerative Medicine visit http://www.vet-stem.com or call 858-748-2004.
See the original post here:
Vet-Stem, Inc. Founder and CEO, Robert Harman, DVM, Invited to Speak at the Adult Stem Cell Therapy and Regenerative ...
Uncategorized
Comments Off on Vet-Stem, Inc. Founder and CEO, Robert Harman, DVM, Invited to Speak at the Adult Stem Cell Therapy and Regenerative … |
August 16th, 2013
NIH joins opposition to charging patients for experimental stem cell therapy
By LizaAVILA
By: Jet Villa, InterAksyon.com August 16, 2013 8:24 AM
InterAksyon.com The online news portal of TV5
MANILA, Philippines -- (UPDATE - 10:12 a.m.) A consultant of Secretary Enrique Ona resigned Friday, calling the Health chiefs position that patients undergoing experimental stem cell therapy should pay unacceptable.
Dr. Anthony Leachon, who is in Davao City, said he emailed his resignation letter to Ona.
It is with deep regret that I'm resigning asDepartment of Health consultant for non-communicable diseases effective today (Friday). I have been privileged and honored to be a part of your administration even as a one peso a year consultant. I value our friendship and camaraderie which started years ago, Leachon, vice president of the Philippine College of Physicians and Onas consultant for non-communicable diseases, wrote.
Because his position is directly opposed to Onas, Leachon told the Health secretary, I believe I have lost your trust and confidence and I might not be effective serving the DOH and fighting the PCP and medical societies ' cause in the service of the Filipino patient.
Leachon was Onas consultant for non-communicable diseases since November 2011.
Ang pinaka-hindi ko nagustuhan ay yung sisingilin ang pasyente kahit clinical trial pa lang. Yon ang unacceptable sa akin (What I disagree with most is charging patients even if what they undergo are just clinical trials. That is unacceptable), Leachon said.
His resignation came as the National Health Institute, the research arm for health sciences of the University of the Philippines-Manila, joined the growing opposition to the Health secretarys stand on experimental stem cell therapy.
Leachon, a cardiologist at the Manila Doctors Hospital, called Onas position a complete violation of the Code of Ethics (for doctors) and being the secretary of health, alam niya dapat yon (he should know that). This is not a sign of ignorance, pero siguro may mga taong iba ang sinasabi sa kaniya (but there may be people telling him otherwise).
Visit link:
NIH joins opposition to charging patients for experimental stem cell therapy
Uncategorized
Comments Off on NIH joins opposition to charging patients for experimental stem cell therapy |
August 16th, 2013
Consultant quits over DOH chief's stand on stem cell therapy
By JoanneRUSSELL25
By: Jet Villa, InterAksyon.com August 16, 2013 8:24 AM
InterAksyon.com The online news portal of TV5
MANILA, Philippines -- (UPDATE - 10:12 a.m.) A consultant of Secretary Enrique Ona resigned Friday, calling the Health chiefs position that patients undergoing experimental stem cell therapy should pay unacceptable.
Dr. Anthony Leachon, who is in Davao City, said he emailed his resignation letter to Ona.
It is with deep regret that I'm resigning asDepartment of Health consultant for non-communicable diseases effective today (Friday). I have been privileged and honored to be a part of your administration even as a one peso a year consultant. I value our friendship and camaraderie which started years ago, Leachon, vice president of the Philippine College of Physicians and Onas consultant for non-communicable diseases, wrote.
Because his position is directly opposed to Onas, Leachon told the Health secretary, I believe I have lost your trust and confidence and I might not be effective serving the DOH and fighting the PCP and medical societies ' cause in the service of the Filipino patient.
Leachon was Onas consultant for non-communicable diseases since November 2011.
Ang pinaka-hindi ko nagustuhan ay yung sisingilin ang pasyente kahit clinical trial pa lang. Yon ang unacceptable sa akin (What I disagree with most is charging patients even if what they undergo are just clinical trials. That is unacceptable), Leachon said.
His resignation came as the National Health Institute, the research arm for health sciences of the University of the Philippines-Manila, joined the growing opposition to the Health secretarys stand on experimental stem cell therapy.
Leachon, a cardiologist at the Manila Doctors Hospital, called Onas position a complete violation of the Code of Ethics (for doctors) and being the secretary of health, alam niya dapat yon (he should know that). This is not a sign of ignorance, pero siguro may mga taong iba ang sinasabi sa kaniya (but there may be people telling him otherwise).
The rest is here:
Consultant quits over DOH chief's stand on stem cell therapy
Uncategorized
Comments Off on Consultant quits over DOH chief's stand on stem cell therapy |
August 16th, 2013
Solon calls for probe into stem cell therapy
By raymumme
by Buena Bernal Posted on 08/15/2013 7:59 PM |Updated 08/16/2013 12:05 AM
PROBE STEM CELL THERAPY. Rep Paulino 'Doy' Leachon files a resolution to probe the conduct of stem cell therapy in the Philippines. Photo grabbed from islandsentinel.com
MANILA, Philippines - Rep Paulino Salvador "Doy" Leachon of Oriental Mindoro's 1st district filed on Thusday, August 15, a house resolution calling for a congressional inquiry in aid of legislation on the conduct of stem cell therapy in the country.
House Resolution 215 was filed a day after Leachon's scheduled privilege speech, calling for the resignation of Health Secretary Enrique Ona over the cabinet official's stand on stem cell therapy.
READ: Leachon asks Ona to resign over stem cell issue
The 40-year-old lawmaker also urged concerned government agencies to step up their regulatory oversight. These agencies include the Department of Health (DOH), the Food and Drug Administration (FDA), and the Professional Regulation Commission (PRC).
First attempt to regulate
Government regulation of stem cell treatment is still in its infancy stage, with the guidelines for accreditation of facilities released only in March.
It is DOH's first attempt at regulating the practice, despite the therapy having been administered by Filipino physicians for years now.
The types of stem cell treatment that are allowed, prohibited, and restricted (i.e. allowed but with limitations) in the facilities to be accredited by August 31 are listed in the released guidelines.
Read the original here:
Solon calls for probe into stem cell therapy
Uncategorized
Comments Off on Solon calls for probe into stem cell therapy |
August 16th, 2013
Hello Doctor Zee 24 Taas Dr Nandini Gokulchandran talk show on stem cell therapy treatment – Video
By JoanneRUSSELL25
Hello Doctor Zee 24 Taas Dr Nandini Gokulchandran talk show on stem cell therapy treatment
Hello Doctor Zee 24 Taas Dr Nandini Gokulchandran talks about Brain Related different types diseases and for them effective Stem Cell Therapy Treatments Stem...
By: Neurogen Brain and Spine Institute
See the original post here:
Hello Doctor Zee 24 Taas Dr Nandini Gokulchandran talk show on stem cell therapy treatment - Video
Uncategorized
Comments Off on Hello Doctor Zee 24 Taas Dr Nandini Gokulchandran talk show on stem cell therapy treatment – Video |
August 15th, 2013
Stem Cell Therapy Treatment for Congenital Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. – Video
By Dr. Matthew Watson
Stem Cell Therapy Treatment for Congenital Muscular Dystrophy by Dr Alok Sharma, Mumbai, India.
Improvement seen in just 5 day after Stem Cell Therapy Treatment for Congenital Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy ...
By: Neurogen Brain and Spine Institute
Uncategorized
Comments Off on Stem Cell Therapy Treatment for Congenital Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. – Video |
August 15th, 2013
My Stem Cell Therapy Fundraiser – Video
By NEVAGiles23
My Stem Cell Therapy Fundraiser
Explain how I was able to raise funds toward my Stem Cell Therapy to treat Multiple Sclerosis...
By: Tiffany Talks Multiple Sclerosis
Read this article:
My Stem Cell Therapy Fundraiser - Video
Uncategorized
Comments Off on My Stem Cell Therapy Fundraiser – Video |
August 15th, 2013
NewsLife: DOH calls for registration of stem cell therapy operators – Video
By daniellenierenberg
NewsLife: DOH calls for registration of stem cell therapy operators
NewsLife - DOH calls for registration of stem cell therapy operators (Reported By: Noel Perfecto) - [August 12, 2013] For more news, visit: #9659;http://www.ptvne...
By: PTV PH
Read more here:
NewsLife: DOH calls for registration of stem cell therapy operators - Video
Uncategorized
Comments Off on NewsLife: DOH calls for registration of stem cell therapy operators – Video |
August 14th, 2013
Bill filed to regulate stem cell therapy in PH
By LizaAVILA
By Christian V. Esguerra Philippine Daily Inquirer
La Union Rep. Eufranio Eriguel. Photo from congress.gov.ph
MANILA, PhilippinesA congressman has joined the call to regulate stem cell therapy administered in the country.
La Union Rep. Eufranio Eriguel has introduced House Bill No. 212, which would put up a bioethics advisory board that would establish ethical standards governing the practice of stem cell research and therapy.
Under the proposed Stem Cell Research and Therapy Act of 2013, the board shall be responsible for addressing contentious ethical, scientific and legal issues in stem cell and cell-based or cellular research and therapies.
There is much to be learned from stem cell therapy, its benefits and application in the cure of some of the most devastating diseases and conditions. As of now, the full promise of stem cell treatment remains unknown, Eriguel said in a statement.
But the cost far outweighs its benefits because it is very expensive and only a few physicians are trained to do stem cell procedures here in the Philippines.
In his proposal, the board will be headed by the health secretary and the National Transplant Ethics Committee, while the Food and Drug Administration director will serve as vice chairman.
A proposed institutional review committee will be tasked to approve stem cell and cell-based or cellular research and therapies based on existing Department of Health guidelines.
Follow Us
Continued here:
Bill filed to regulate stem cell therapy in PH
Uncategorized
Comments Off on Bill filed to regulate stem cell therapy in PH |
August 14th, 2013
DOH gives health facilities engaged in stem cell therapy until Aug. 31 to register
By Sykes24Tracey
By: Jet Villa, InterAksyon.com August 13, 2013 8:42 AM
InterAksyon.com The online news portal of TV5
MANILA, Philippines - The Department of Health (DOH) has given all health facilities practicing stem cell therapy and companies importing and producing stem cell products untilAug. 31to apply for accreditation and product registration, respectively.
Nick Lutero, director of the DOH-Bureau of Health Facilities and Services, said it will be considered illegal for facilities to do stem cell procedures if they fail to comply with the requirement.
Papatigil namin ang pag-conduct ng therapy. For those still continuing to practice, I think we have sufficient laws, particularly on the illegal practice of medicine. They could be criminally liable, he said in a chance interview.
Lutero lamented that only five hospitals have applied for registration although the DOH had issued the guidelines on this since March.
We have done preliminary visits sa mga hospitals na ito at mukang based sa initial inspection, merong sufficient compliance sa mga facilities, he said.
Companies importing and producing stem cell products, on the other hand, should apply for registration with the Food and Drug Administration, an agency attached to the DOH.
Products that will not be applied for registration will also be considered illegal after the deadline.
Experimental treatment not for free
See original here:
DOH gives health facilities engaged in stem cell therapy until Aug. 31 to register
Uncategorized
Comments Off on DOH gives health facilities engaged in stem cell therapy until Aug. 31 to register |
August 13th, 2013
DOH sets deadline for stem cell therapy accreditation
By NEVAGiles23
Manila, Philippines -- Hospitals and health facilities offering stem cell therapy have until August 31 to apply for accreditation from the Department of Health (DoH).
DoH Secretary Enrique T. Ona said a number of hospitals in Metro Manila have already applied for accreditation to perform this "innovative" treatment that has not yet been accepted as standard mode of care in the country since it needs further tests and several more layers of research.
In the first mid-year convention of the Philippine Society for Stem Cell Medicine at the Manila Hotel yesterday, Ona reiterated that stem cell therapy is "the future of medicine."
"Stem cell therapy is not a cure-all medical treatment. Patients have yet to be presented first with standard of treatment, and in many cases, stem cell treatments have to be done in conjunction with other standard modalities of treatment," he said.
The Bureau of Health Facilities and Services (BHFS) of the DoH is accepting the applications for accreditation while a bio-ethics committee and a hospital-based review board will go over the applications and decide on their approval.
Five big hospitals in Metro Manila have already applied for accreditation, said Nick Lutero, chief of the BHFS.
Lutero said initial checks have revealed that these hospitals possess the required equipment needed for the treatment but they would still have to check on requirements set by the Food and Drug Administration (FDA) in relation to the practice.
Lutero said institutions that are offering stem cell treatments can still perform the procedures pending the approval of applications. However, once formal accreditations are already given, unaccredited institutions should cease offering stem cell therapy.
More here:
DOH sets deadline for stem cell therapy accreditation
Uncategorized
Comments Off on DOH sets deadline for stem cell therapy accreditation |
August 12th, 2013
Editorial: Philippine Society for Stem Cell Medicine and Philippine Medical Association 1st Midyear Convention to be …
By raymumme
Two organizations of Filipino medical practitioners - the Philippine Medical Association (PMA) and the Philippine Society for Stem Cell Medicine (PSSCM) - are partnering to come up with ideas to help professionalize and organize the practice of stem cell therapy in the Philippines during their 1st Midyear Convention at the Historic Landmark Manila Hotel on August 12-13, 2013.
With the theme ''Current Status of the Practice of Stem Cell Therapy in the Philippines,'' the convention is expected to take up various issues surrounding stem cell therapy, which, despite the controversies, is increasingly becoming popular for treatment of certain illnesses. Among the scheduled topics for discussion in the convention are Food and Drug Administration Circular on Stem Cell Products, DOH Stem Cell Guidelines, Current Trends on Stem Cell Therapy, Clinical Use of Autologous, Adipose Derived Stem Cells, Photo-Activated Platelet-Rich Plasma for Orthopedic and Rehabilitation Applications, Umbilical Cord Blood and Cord Tissue for Stem Cell Therapy, Stem Cell Therapy in the Philippines other than for Cancer Rejuvenation, and Quality Control in Cell Transplantation.
Administrative Order 2013-0012 issued by the Department of Health (DOH) rules on the practice of stem cell, cell-based therapy, and accreditation of health facilities engaging in the treatment in the Philippines. The Professional Regulation Commission Board of Medicine (PRCBOM) requires foreign doctors wishing to practice stem cell therapy in the country to get a special temporary permit, citing their education, training, and clinical experience.
The PMA, the country's premier medical organization, has 70,000 members in 118 component medical societies, eight specialty divisions, 73 specialty and subspecialty societies, and 39 affiliate societies all over the archipelago, who advocate professional advancement and promote public health. The newly founded PSSCM is composed of physicians doing stem cell therapy and transplant. It is working closely with DOH, PRCBOM, and PMA to regulate the practice of Stem Cell therapy and protect patients.
We congratulate the Philippine Medical Association, headed by its President Dr. Leo O. Olarte, and the Philippine Society for Stem Cell Medicine, led by Dr. Rey Melchor F. Santos, in their coordinative efforts to educate and inform the public on the status of stem cell treatment as a novel medical approach in the Republic of the Philippines. CONGRATULATIONS AND MABUHAY!
Read this article:
Editorial: Philippine Society for Stem Cell Medicine and Philippine Medical Association 1st Midyear Convention to be ...
Uncategorized
Comments Off on Editorial: Philippine Society for Stem Cell Medicine and Philippine Medical Association 1st Midyear Convention to be … |
August 11th, 2013